Concepedia

Publication | Open Access

GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study

DOIFull Paper Access

13

Citations

13

References

2023

Year

Erica Villa, Rossella Donghia, Valentina Baldaccini, Calogero C. Tedesco, Endrit Shahini, Raffaele Cozzolongo, S. Ascari, Pasqua Letizia Pesole, Sergio Coletta, Rosina Maria Critelli,
Hepatology Communications

Abstract

GALAD is the most reliable and accurate score system to detect HCC risk of development in patients with compensated advanced chronic liver disease.

References

YearCitations

Page 1